Targeted Next-Generation Sequencing Combined With Circulating-Free DNA Deciphers Spatial Heterogeneity of Resected Multifocal Hepatocellular Carcinoma

Abstract

BackgroundHepatocellular carcinoma (HCC) has a high risk of recurrence after surgical resection, particularly among patients with multifocal HCC. Genomic heterogeneity contributes to the early recurrence. Few studies focus on targeted next-generation sequencing (tNGS) to depict mutational footprints of heterogeneous multifocal HCC.MethodsWe conducted tNGS with an ultra-deep depth on 31 spatially distinct regions from 11 resected multifocal HCC samples. Matched preoperative peripheral circulating-free DNA (cfDNA) were simultaneously collected. Genomic alterations were identified and compared to depict the heterogeneity of multifocal HCC.ResultsWidespread intertumoral heterogeneity of driver mutations was observed in different subfoci of multifocal HCC. The identified somatic mutations were defined as truncal drivers or branchy drivers according to the phylogenetic reconstruction. TP53 and TERT were the most commonly altered truncal drivers in multifocal HCC, while the most frequently mutated branchy driver was TSC2. HCC patients with a higher level of intertumoral heterogeneity, defined by the ratio of truncal drivers less than 50%, had a shorter RFS after surgical resection (HR=0.17, p=0.028). Genome profiling of cfDNA could effectively capture tumor-derived driver mutations, suggesting cfDNA was a non-invasive strategy to gain insights of genomic alterations in patients with resected multifocal HCC.ConclusionsTruncal mutations and the level of genomic heterogeneity could be identified by tNGS panel in patients with resected multifocal HCC. cfDNA could serve as a non-invasive and real-time auxiliary method to decipher the intertumoral heterogeneity and identify oncodrivers of multifocal HCC.

Circulating Tumor DNA in Human Papillomavirus–Mediated Oropharynx Cancer

“…Circulating viral-host chimera ctDNA is quickly becoming a valuable diagnostic and prognostic tool in virus-associated cancers, including HPV-associated oropharyngeal carcinoma and cervical cancer and hepatitis B virus–associated hepatocellular carcinoma. Integrated viral ctDNA sequences allow ultrasensitive detection without background interference, may provide tumor location through virus tropism, and can be used to monitor clonal expansion in tumors related to oncogenic viruses 37,56–76 . Furthermore, specific viral integration sites into the cellular genome (integration “hotspots”) may provide information about the tumor phenotype 75 …”

Liquid biopsy for children with central nervous system tumours: Clinical integration and technical considerations

“…Increased shedding of ctDNA from more aggressive, resistant clones into the blood has been reported in adult patients with breast, gastro-intestinal (GI), and lung cancer (60-62). Multi-regional tissue sequencing compared to cfDNA in adult non-small cell lung cancer (NSCLC) (60) and hepatocellular carcinoma (63)(64)(65) showed that ctDNA reflects the truncal-branching hierarchy determined by tissue sequencing but it does so incompletely. In the paediatric setting there is very little information to date about the potential of cfDNA to assess the spatial heterogeneity of tumours.…”

Cancer Evo–Dev: A Theory of Inflammation-Induced Oncogenesis

“…As HCC has many etiological causes and experience a long evolutionary process, the somatic mutation spectrum is heterogeneous (8,98). For example, the mutation in the gene of telomerase reverse transcriptase (TERT) is universal in HCC patients, but its mutation site and patterns are significantly different between HCC patients caused by chronic HBV infection and those caused by alcohol or HCV (99)(100)(101). The high-frequent single-gene mutations in HCV-or alcohol-induced HCC are rarely detected in HBV-induced HCC, suggesting the different mechanisms of cancer evolution.…”